Rezultati

eNauka >  Results >  Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
Title: Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
Authors : Stupp, Roger; ...; Grujicic, Danica M; ...; (broj, koautora 37)
Issue Date: 2014
Publication: LANCET ONCOLOGY
ISSN: 1470-2045 Lancet Oncology Search Idenfier
Type: Article
Collation: vol. 15 br. 10 str. 1100-1108
DOI: 10.1016/S1470-2045(14)70379-1
WoS-ID: 000341312500051
Scopus-ID: 2-s2.0-84908563697
URI: https://enauka.gov.rs/handle/123456789/812245
Project: Merck KGaA, Darmstadt, Germany
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
21a+M21a+

924
SCOPUSTM
642
OpenCitations
855
WEB OF SCIENCETM
Alt metrika
Dimensions
Unpaywall

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.